JOEL ONAFOWOKAN: Open Payments
NPI 1790745495 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$582 in 31 payments from 11 companies in 2025. Trend: 2023 $563 · 2024 $670 · 2025 $582
Food & beverage: $582
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 6 | $102 |
| Lilly USA, LLC | 5 | $92 |
| ABBVIE INC. | 5 | $89 |
| Amgen Inc. | 4 | $76 |
| Novo Nordisk Inc | 3 | $58 |
| Virtus Pharmaceuticals LLC | 2 | $40 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| Otsuka America Pharmaceutical, Inc. | 1 | $32 |
| SCILEX PHARMACEUTICALS INC. | 1 | $22 |
| Paratek Pharmaceuticals, Inc. | 1 | $20 |
Products named: TRELEGY ELLIPTA, MOUNJARO, KRYSTEXXA, VRAYLAR, LEVORPHANOL TARTRATE, Ozempic, REXULTI, ELYXYB - CELECOXIB.
Industry payments across NC — which companies pay providers there.
